DekaBank Deutsche Girozentrale’s Insmed INSM Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.02M	Hold	50,000	–	–	0.01%	478
2026 Q1	$8.19M	Hold	50,000	–	–	0.01%	479
2025 Q4	$1.49M	Hold	50,000	–	–	﹤0.01%	811
2025 Q3	$7.05M	Hold	50,000	–	–	0.01%	521
2025 Q2	$4.96M	Hold	50,000	–	–	0.01%	567
2025 Q1	$3.86M	Hold	50,000	–	–	0.01%	616
2024 Q4	$3.43M	Hold	50,000	–	–	0.01%	645
2024 Q3	$3.6M	Hold	50,000	–	–	0.01%	650
2024 Q2	$3.35M	Hold	50,000	–	–	0.01%	658
2024 Q1	$1.36M	Hold	50,000	–	–	﹤0.01%	818
2023 Q4	$1.58M	Hold	50,000	–	–	﹤0.01%	815
2023 Q3	$1.28M	Hold	50,000	–	–	﹤0.01%	834
2023 Q2	$1.01M	Hold	50,000	–	–	﹤0.01%	878
2023 Q1	$831K	Sell	50,000 -48,600	-49%	-$944K	﹤0.01%	909
2022 Q4	$1.96M	Hold	98,600	–	–	0.01%	726
2022 Q3	$2.14M	Hold	98,600	–	–	0.01%	694
2022 Q2	$1.96M	Hold	98,600	–	–	0.01%	730
2022 Q1	$2.26M	Sell	98,600 -43,500	-31%	-$1.01M	0.01%	728
2021 Q4	$3.87M	Buy	142,100 +7,900	+6%	+$226K	0.01%	622
2021 Q3	$3.52M	Hold	134,200	–	–	0.01%	614
2021 Q2	$3.92M	Hold	134,200	–	–	0.01%	583
2021 Q1	$4.32M	Buy	134,200 +3,500	+3%	+$134K	0.01%	524
2020 Q4	$4.37M	Buy	130,700 +14,700	+13%	+$537K	0.02%	486
2020 Q3	$3.73M	Buy	+116,000	New	+$3.33M	0.02%	465
2019 Q4	–	Sell	-25,900	Closed	-$473K	–	1177
2019 Q3	$473K	Sell	25,900 -25,900	-50%	-$500K	﹤0.01%	779
2019 Q2	$1.31M	Buy	51,800 +18,300	+55%	+$510K	0.01%	726
2019 Q1	$731K	Sell	33,500 -2,400	-7%	-$62.2K	﹤0.01%	843
2018 Q4	$467K	Buy	35,900 +2,400	+7%	+$38.3K	﹤0.01%	842
2018 Q3	$731K	Sell	33,500 -900	-3%	-$20.3K	﹤0.01%	861
2018 Q2	$826K	Hold	34,400	–	–	0.01%	794
2018 Q1	$758K	Sell	34,400 -700	-2%	-$18.4K	0.01%	787
2017 Q4	$411K	Hold	35,100	–	–	﹤0.01%	858
2017 Q3	$411K	Hold	35,100	–	–	﹤0.01%	864
2017 Q2	$607K	Hold	35,100	–	–	﹤0.01%	797
2017 Q1	$603K	Sell	35,100 -3,000	-8%	-$46.3K	0.01%	709
2016 Q4	$513K	Buy	38,100 +2,900	+8%	+$39.6K	0.01%	655
2016 Q3	$491K	Hold	35,200	–	–	0.01%	670
2016 Q2	$348K	Buy	35,200 +8,600	+32%	+$100K	﹤0.01%	754
2016 Q1	$328K	Sell	26,600 -4,800	-15%	-$63.1K	﹤0.01%	739
2015 Q4	$589K	Buy	31,400 +500	+2%	+$8.81K	0.01%	663
2015 Q3	$575K	Buy	30,900 +1,700	+6%	+$42.4K	0.01%	661
2015 Q2	$713K	Buy	29,200 +5,800	+25%	+$132K	0.01%	624
2015 Q1	$486K	Buy	+23,400	New	+$412K	0.01%	724

Other funds holding INSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

DekaBank Deutsche Girozentrale's INSM Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Insmed (INSM) position steady in Q2 2026 at 50,000 shares worth $8.02M. The position accounts for 0.01% of the portfolio, ranked #478.

DekaBank Deutsche Girozentrale first reported a position in INSM in Q1 2015 and has held it in 43 quarters since. The position peaked at $8.19M in Q1 2026. 297 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

DekaBank Deutsche Girozentrale held 50,000 shares of Insmed worth $8.02M as of Q2 2026.
DekaBank Deutsche Girozentrale left its Insmed share count unchanged in Q2 2026.
Insmed made up 0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #478 holding.
DekaBank Deutsche Girozentrale first reported a position in Insmed in Q1 2015 and has held it in 43 quarters since.
DekaBank Deutsche Girozentrale's Insmed position peaked at $8.19M in Q1 2026.
297 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.